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OBJECTIVE — We studied the relationships of diabetic ulcer wound ﬂuid matrix metallo-
proteinases (MMPs), tissue inhibitors of metalloproteinases (TIMPs), and transforming growth
factor-ß1 (TGF-ß1) with wound healing rate.
RESEARCH DESIGN AND METHODS — The ulcers were cleansed to remove exu-
dates, and wound ﬂuids were collected for analysis of MMP-2 and -9, TIMP-1, and TGF-ß1.
RESULTS — At presentation, MMP-9 and the MMP-9–to–TIMP-1 ratio correlated inversely
with the wound healing rate at 28 days (P  0.001). MMP-9 and the MMP-9–to–TIMP-1 ratio
were lower in the 23 patients who achieved complete healing at 12 weeks versus the 39 who did
not. The pro–MMP-9 concentration was predictive of healing within 12 weeks. Addition of
cutoffs for TIMP-1 (480 pg/ml) and TGF-ß (115 pg/ml) further improved its predictive
power (area under the curve 0.94).
CONCLUSIONS — TheseﬁndingssuggestthatamilieuwithhighMMP-9maybeindicative
of inﬂammation and poor wound healing. Measurements of MMP-9, TIMP-1, and TGF-ß in
wound ﬂuid may help to identify ulcers at risk of poor healing.
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D
iabetic foot ulcers often fail to heal,
and the mechanism is not well ex-
plained (1). In previous studies of
wounds, delayed healing is characterized
by an increase in matrix metalloprotein-
ases (MMPs), a decrease in the tissue in-
hibitors of metalloproteinases (TIMPs),
andareductioninsomegrowthfactors,in
particular, transforming growth factor-
(TGF-) (2–9). Both MMPs and TIMPs
are secreted by cells involved in wound
healing, and their concentrations vary ac-
cording to the phase of healing (4,6).
Studies of diabetic foot ulcer wounds
in humans are limited as a result of the
difﬁculty of obtaining tissue samples.
Wound ﬂuid can be obtained noninva-
sively and could potentially overcome
this problem. The clinical relevance of
studyingwoundﬂuidissupportedbyour
previous report that high bacterial count
indiabeticwoundﬂuidhasanegativeim-
pact on wound healing (10). Therefore,
the aim of this study was to measure
MMP-9,MMP-2,TIMP-1,andTGF-1in
wound ﬂuid obtained from diabetic foot
ulcers and to examine their relationships
with wound healing.
RESEARCH DESIGN AND
METHODS— Patient characteristics
are shown in Table 1. The majority of pa-
tients had type 2 diabetes (n  56), and
their ulcers were classiﬁed as neuropathic
(n  48), postsurgical (n  9), or neuro-
ischemic (n  5) and graded according to
the Texas Grading System (11). The ul-
cers had been present for 2–10 weeks be-
fore presentation. All patients were seen
weekly for debridement, ofﬂoading, and
other treatments during the initial 4
weeks and attended approximately
monthlyvisitsthereafter.Antibioticswere
prescribed for 83% of individuals. The
protocolwasapprovedbytheethicscom-
mittee of the area.
Woundﬂuidswerecollectedfromthe
ulcer site at the ﬁrst clinic visit and after 4
weeks of treatment. Samples were stored
at 20°C for quantitation of MMP-2 and
-9 by zymography (12) and TIMP-1 and
TGF-1 by enzyme-linked immuno-
sorbentassay.Ulcersizeandwoundheal-
ing rates (WHRs) were determined as
previously described (10).
Students t test or one-way ANOVA
was used for comparisons. Multiple re-
gression analysis was used to determine
the relationships between WHR4 weeks,
age, duration of diabetes and ulceration,
wound ﬂuid pro– and active–MMP-9 and
-2, TIMP-1, and TGF-1. Receiver oper-
ating characteristic analysis was used to
determine thresholds for pro–MMP-9 in
predicting healing within 12 weeks.
RESULTS— At 4 weeks, none of the
ulcers had healed, but by 12 weeks, 23 of
the 62 ulcers had completely healed.
Therewerenodifferencesinage,duration
of diabetes, or initial size of the ulcer be-
tween the healed and unhealed groups
(Table 1).
Wound ﬂuid pro–MMP-9 and pro–
MMP-9–to–TIMP-1 ratio at presentation
correlated signiﬁcantly with WHR4 weeks
(r  0.4538, P  0.001, and r  0.4959,
P  0.0001, respectively). This relation-
ship was not evident for MMP-2 or
TIMP-1. The concentrations of pro– and
active–MMP-9 in the wound ﬂuid ob-
tained at presentation were signiﬁcantly
higher and those of TIMP-1 and TGF-1
signiﬁcantly lower in ulcers that subse-
quently failed to heal than in ulcers that
healed within 12 weeks (Table 1). When
the data were expressed as pro–MMP-9–
to–TIMP-1 and active–MMP-9–to–
TIMP-1 ratios, the difference between the
healed and unhealed groups was further
enhanced. This pattern of higher MMP-9
was evident in both stage B and stage C
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for comparison in stages A and D) and
remained so if only the 48 neuropathic
ulcers were analyzed (Table 1). The pro–
and active–MMP-2 concentrations were
also slightly higher (1.5-fold) in the un-
healed group, but only the ratios of pro–
and active–MMP-2 to TIMP-1 (threefold)
attained signiﬁcance. Wound ﬂuid ob-
tained after 4 weeks of treatment also
showed the same pattern of higher pro–
MMP-9(meanSDunhealedconcentra-
tion7.284.62vs.healedconcentration
4.73  4.47 g/ml), higher active–
MMP-9 (1.87  3.19 vs. 1.32  1.97 g/
ml), and a higher pro–MMP-9–to–
TIMP-1 ratio (23.17  3.81 vs. 8.36 
10.95).The proteinconcentrationofthe
wound ﬂuid was 10.4  5.5 mg/ml in
the unhealed and 13.1  6.3 mg/ml in
the healed group.
Wound ﬂuid pro–MMP-9, active–
MMP-9, and TIMP-1 at presentation ac-
counted for 32% of the variance in
healing rate. Duration of diabetes, age,
initial wound size, and TGF-1 were not
statistically signiﬁcant determinants.
Measurement of pro–MMP-9 with addi-
tion of cutoffs for TIMP-1 at 480 pg/ml
and TGF-1a t115 pg/ml (respective
median values for healed wounds) was
the best predictor of wound healing (area
under the curve 0.94; P  0.00001). The
sensitivity and speciﬁcity were 87 and
91%, respectively, and predicted out-
come in 94% of cases.
CONCLUSIONS— The results of
our study have shown for the ﬁrst time
that high wound ﬂuid concentrations of
MMP-9 and high MMP-9–to–TIMP-1 ra-
tios predict poor wound healing in dia-
betic foot ulcers. The mechanism of
increased MMP-9 is uncertain. However,
it is likely to be related to increased in-
ﬂammation because MMP-9 is expressed
mainly by neutrophils and macrophages,
both cell types important to the inﬂam-
matory response (13). This pattern of in-
creased MMP-9 in poorly healing ulcers
was observed in varying types of diabetic
foot ulcers, suggesting that it is more
strongly linked with the healing process
rather than with underlying etiology. We
have previously shown that high wound
ﬂuid bacterial count, even in the absence
of overt infection, is also predictive of
poor wound healing (10). It is possible
that high bacterial count and high MMPs
aremechanisticallylinkedinthisregard.As
such, the results could be affected by anti-
biotic therapy, which most of our patients
were given, but we have not systematically
examined this aspect. It is unlikely that the
pattern we have observed is due to in-
creased exudates in nonhealing wounds.
First, the protein concentration of the non-
healed ulcer group was actually lower than
that of the healed group. Second, a simple
change in the amount of exudates should
not affect the various components such as
MMPs and TIMPs differently.
Our study using wound ﬂuid col-
lected by an easy noninvasive technique is
animportantsteptofacilitateinvestigations
in this area of study. One of the frustrations
for clinicians treating diabetic foot ulcers is
that there is not a simple test that can inte-
gratevariousriskfactorstoallowprediction
of achieving wound healing. Although our
results need conﬁrmation, it would be very
useful if an index calculated from the mea-
surements of MMPs, TIMP-1, and TGF-1
at the initial presentation could assist in
prognostication.
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